CONMED Corporation (CNMD)
NYSE · Healthcare · Medical Devices
$47.33+2.18%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $1.4B
- P/E (trailing)
- 25.6
- Forward P/E
- 9.9
- Dividend yield
- 1.7%
- 52-week range
- $31.44 – $53.66
- 52-week change
- −0.32%
- EPS (trailing)
- $1.85
- Next earnings
- Oct 28, 2026
Fiscal year to Dec 2025
- Revenue
- $1.4B (+5.18%)
- Net income
- $47.1M
- Operating margin
- 7.5%
- Diluted EPS
- $1.51
- Free cash flow
- $151M
From the company’s annual report on SEC EDGAR.
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.
Headquarters: Largo, United States · 3,900 employees · conmed.com